<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e>, or <z:hpo ids='HP_0002667'>nephroblastoma</z:hpo>, is an embryonal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> of the kidney with an incidence of approximately 1 in 10,000 live births </plain></SENT>
<SENT sid="1" pm="."><plain>It occurs in both <z:hpo ids='HP_0003745'>sporadic</z:hpo> and familial forms, but only 1% of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> patients have a positive family history </plain></SENT>
<SENT sid="2" pm="."><plain>The molecular genetics of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> have been the subject of extensive research and at least three genes (WT1, WT2, WT3) have been implicated </plain></SENT>
<SENT sid="3" pm="."><plain>WT1 has been mapped to 11p13, and it has been suggested that loss or inactivation of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressor gene at 11p13 might be a primary event in the development of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The WT2 gene maps to 11p15 in the region of the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann</z:e> locus </plain></SENT>
<SENT sid="5" pm="."><plain>The WT3 locus is likely to be located to chromosome 16q </plain></SENT>
<SENT sid="6" pm="."><plain>The understanding of the molecular genetics of <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> is reviewed briefly </plain></SENT>
</text></document>